RXRX
RECURSION PHARMACEUTICALS, INC.
Overview
RECURSION PHARMACEUTICALS, INC is a Healthcare company operating in Biotechnology with a $1.69B market cap.
Most recent reported earnings: Q2 FY2026 (Aug 3, 2026).
9 earnings calls indexed on Spoken Alpha.
Behavioral analysis
Management language signature
Disclosures
Investor Relations
Extracted from Unknown source, 2026-06-21.
Transcripts
Recent earnings calls
Most recent calls indexed for this ticker. Open any call to drill into prepared remarks and Q&A.
- Q1 FY2026Earnings2026-05-061 Q&A exchange
- Q4 FY2025Earnings2026-02-25
- Q3 FY2025Earnings2025-11-051 Q&A exchange
- Q2 FY2025Earnings2025-08-051 Q&A exchange
- Q1 FY2025Earnings2025-05-051 Q&A exchange
- Q4 FY2024Earnings2025-02-281 Q&A exchange
- Q2 FY2024Earnings2024-08-091 Q&A exchange
- Q1 FY2024Earnings2024-05-09
- Q4 FY2023Earnings2024-02-272 Q&A exchanges
History
Earnings history
- Q2 FY20262026-08-03EPS— vs $-0.25—Rev— vs ——EODHD
| Period | Reported | EPS actual | EPS consensus | EPS surprise | Revenue actual | Revenue consensus | Rev. surprise | Source |
|---|---|---|---|---|---|---|---|---|
| Q2 FY2026 | 2026-08-03 | — | $-0.25 | — | — | — | — | EODHD |
Source: EODHD. RXRX reported actuals as published; sparse fields render as —.
Track Record
SampleSpoken Alpha tracks RXRX's historical accountability: how often management beat consensus, how the stock reacted, and how guidance evolved across the cycle. The figures below are illustrative placeholder data generated for layout — they will be replaced with real deviation metrics, True Consensus values, and EODHD price reactions as those data layers land.
Beats consensus 4/10 quarters with 80% positive reaction rate
SampleConsistent execution against consensus with the stock following through is the cleanest signal a guidance regime is calibrated. Worth watching for the inflection where execution deteriorates relative to the bar.
Missed in 2 of the last 4 quarters
SampleRecent misses matter more than long-window beat rate — the trailing 12 months drives the analyst model and the next-print bar.
Quarterly beats & misses
Sample| Quarter | Actual EPS | Consensus | Surprise | 1D | 5D |
|---|---|---|---|---|---|
| Q1 FY2026 | $2.94 | $3.07 | -4.1% | +3.4% | +4.9% |
| Q4 FY2026 | $3.36 | $3.04 | +10.5% | +0.8% | +1.0% |
| Q3 FY2026 | $3.13 | $3.19 | -1.9% | +1.1% | +0.9% |
| Q2 FY2026 | $3.29 | $3.11 | +5.9% | +4.0% | +5.1% |
| Q1 FY2025 | $2.87 | $2.97 | -3.3% | -1.7% | +0.6% |
| Q4 FY2025 | $3.49 | $3.15 | +10.8% | +7.9% | +5.0% |
| Q3 FY2025 | $3.30 | $3.26 | +1.1% | +7.2% | +9.1% |
| Q2 FY2025 | $3.13 | $3.24 | -3.3% | +0.4% | +1.7% |
| Q1 FY2024 | $3.01 | $3.04 | -1.1% | -1.4% | +0.9% |
| Q4 FY2024 | $2.98 | $3.11 | -4.1% | +5.6% | +8.4% |
Guidance change history
Sample- Q1 FY2026Lowered2026-04-15
- Q4 FY2026Raised2026-13-15
- Q3 FY2026Maintained2026-10-15
- Q2 FY2026Raised2026-07-15
- Q1 FY2025Maintained2025-04-15
- Q4 FY2025Raised2025-13-15
- Q3 FY2025Maintained2025-10-15
- Q2 FY2025Maintained2025-07-15
Top executives
SampleSpoken Alpha builds an accountability record per executive — how the person's own guidance, language, and reactions have evolved across every call they've appeared on. The one-liners below are illustrative placeholder data pending the deviation v1 work. Click any name for the full role timeline and call appearance history.
- Najat KhanCEO4 mo6 callsCurrentSample
CEO since 2026 • 1/2 beats (50%) • last guidance cut Q2 FY2026
- Christopher GibsonCEO8 mo7 callsCurrentSample
CEO since 2025 • 3/4 beats (75%) • last call held guidance Q1 FY2026
- Ben R TaylorCFO7 mo6 callsCurrentSample
CFO since 2025 • 2/4 beats (50%) • last guidance raise Q3 FY2026
- David HallettChief Scientific Officer4 mono recorded callsCurrentSample
OTHER_C_SUITE since 2026 • 1/2 beats (50%) • guidance suspended Q1 FY2026
Peers
Other companies in Healthcare
Sector peers tracked by Spoken Alpha. Each links to the same machine-readable IR surface — earnings calls, executives, and accountability scores.
API
For developers and AI agents
The same data on this page is available as a machine-readable feed via the Spoken Alpha API. One call returns the IR URL, recent transcripts, and accountability scores for RXRX.
$ curl https://api.spokenalpha.com/v1/companies/RXRXFAQ
Frequently asked about RXRX
Where can I find RECURSION PHARMACEUTICALS, INC.'s (RXRX) earnings call transcripts?
Spoken Alpha indexes RXRX's earnings call transcripts at https://spokenalpha.com/companies/RXRX. Each call links to attributed speakers and parsed analyst Q&A. RECURSION PHARMACEUTICALS, INC.'s own investor relations page is at https://ir.recursion.com/.
When was RECURSION PHARMACEUTICALS, INC.'s most recent earnings call?
RECURSION PHARMACEUTICALS, INC. (RXRX) held its most recent earnings call on 2026-05-06, covering fiscal Q1 2026.
What sector is RXRX in?
RECURSION PHARMACEUTICALS, INC. (RXRX) operates in the Healthcare sector (Biotechnology industry).